High Throughput Assessment of Biomarkers in Tissue Microarrays Using Artificial Intelligence: PTEN Loss as a Proof-of-Principle in Multi-Center Prostate Cancer Cohorts – Beyond the Abstract
artificial intelligence technology in everyday pathology practices, management of post-operative prostate cancer patients, risk assessment of prostate cancer using phosphatase and tensin homolog, objective assessment of PTEN loss.